Propensity score analysis of radical proctectomy versus organ preservation using contact X-ray brachytherapy for rectal cancer

被引:8
作者
Gerard, Jean-Pierre [1 ]
Montagne, Lucile [1 ]
Thamphya, Brice [2 ]
Doyen, Jerome [1 ]
Schiappa, Renaud [2 ]
Benezery, Karene [1 ]
Gourgou, Sophie [3 ]
Dejean, Catherine [4 ]
Hannoun-Levi, Jean-Michel [1 ]
机构
[1] Cote dAzur Univ, Ctr Antoine Lacassagne, Dept Radiat Oncol, Nice, France
[2] Cate dAzur Univ, Ctr Antoine Lacassagne, Dept Clin Res Stat, Nice, France
[3] Inst Cancerol Montpellier, Dept Biometry, Montpellier, France
[4] Cote dAzur Univ, Ctr Antoine Lacassagne, Dept Med Phys, Nice, France
关键词
Rectal cancer; Organ preservation; Propensity score; Contact X-ray brachytherapy; CLINICAL COMPLETE RESPONDERS; NEOADJUVANT CHEMORADIOTHERAPY; SPHINCTER PRESERVATION; INTERNATIONAL WATCH; WAIT DATABASE; RADIOTHERAPY; RECURRENCE; SERIES;
D O I
10.1016/j.ctro.2021.12.007
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Introduction: Radical proctectomy (RP-TME) with neo adjuvant chemoradiotherapy (nCRT) remains the standard treatment for T2-T3 rectal cancer. Organ preservation (OP) using CRT and a "watch and wait" strategy (W&W) is a field of research. Planned organ preservation can be proposed for early T1 -T3 using contact X-ray brachytherapy (CXB). We compared the oncological outcomes of both approaches using a propensity score matched-cohort analysis. Material and methods: For comparative analyses between patients with nCRT + RP-TME and patients with CXB + CRT, propensity scores were calculated with logistic regression and multiple imputations for missing data. The variables included in the propensity score model were PS status, T-N stage and rectal circumference extension. Patients were matched 1:1 using the nearest neighbor method with a 0.1 caliper restriction. The 5-year Cancer Specific survival was the primary end point. Results: The Accord 12 phase III trial included 584 patients who treated with nCRT + RP-TME. The CXB cohort included 71 patients with a planned OP. To select OP patient candidate, T4, tumor with extension >66% circumference were eliminated and only patients treated with CXB + CRT were analyzed in the CXB cohort resulting in a total of 374 patients. A one to one paired cohort with 36 patients in each group was derived. These two cohorts were well matched for all confounding factors except for age. The 5-year cancer specific rate showed no significant difference between the two groups (89% in Accord 12 vs 82% in CXB; p = 0.84). At 5 years, rate of metastasis (15% vs 22%, p = 0.54) showed no significant difference. In the CXB group 33/36 patients preserved their rectum. Conclusion: The organ preservation strategy using CXB boost yielded a 5-year cancer specific survival rate similar to patients treated with RP-TME. In selected early T2-3 rectal adenocarcinoma an organ preservation strategy could be offered as a reasonable option.
引用
收藏
页码:70 / 76
页数:7
相关论文
共 26 条
[1]   High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study [J].
Appelt, Ane L. ;
Ploen, John ;
Harling, Henrik ;
Jensen, Frank S. ;
Jensen, Lars H. ;
Jorgensen, Jens C. R. ;
Lindebjerg, Jan ;
Rafaelsen, Soren R. ;
Jakobsen, Anders .
LANCET ONCOLOGY, 2015, 16 (08) :919-927
[2]   Radiation Dose-Response Model for Locally Advanced Rectal Cancer After Preoperative Chemoradiation Therapy [J].
Appelt, Ane L. ;
Ploen, John ;
Vogelius, Ivan R. ;
Bentzen, Soren M. ;
Jakobsen, Anders .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 85 (01) :74-80
[3]   Late toxicities and clinical outcome at 5 years of the ACCORD 12/0405-PRODIGE 02 trial comparing two neoadjuvant chemoradiotherapy regimens for intermediate-risk rectal cancer [J].
Azria, D. ;
Doyen, J. ;
Jarlier, M. ;
Martel-Lafay, I. ;
Hennequin, C. ;
Etienne, P. ;
Vendrely, V. ;
Francois, E. ;
de la Roche, G. ;
Bouche, O. ;
Mirabel, X. ;
Denis, B. ;
Mineur, L. ;
Berdah, J. ;
Mahe, M. ;
Becouran, Y. ;
Dupuis, O. ;
Lledo, G. ;
Seitz, J. ;
Bedenne, L. ;
Gourgou-Bourgade, S. ;
Juzyna, B. ;
Conroy, T. ;
Gerard, J. .
ANNALS OF ONCOLOGY, 2017, 28 (10) :2436-2442
[4]   Management of Rectal Cancer Without Radical Resection [J].
Beets, Geerard L. ;
Figueiredo, Nuno F. ;
Beets-Tan, Regina G. H. .
ANNUAL REVIEW OF MEDICINE, VOL 68, 2017, 68 :169-182
[5]   Clinical response assessment after contact X-Ray brachytherapy and chemoradiotherapy for organ preservation in rectal cancer T2-T3 M0: The time/dose factor influence [J].
Benezery, Karen ;
Montagne, Lucile ;
Evesque, Ludovic ;
Schiappa, Renaud ;
Hannoun-Levi, Jean-Michel ;
Francois, Eric ;
Thamphya, Brice ;
Gerard, Jean-Pierre .
CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2020, 24 :92-98
[6]   Conditional recurrence-free survival of clinical complete responders managed by watch and wait after neoadjuvant chemoradiotherapy for rectal cancer in the International Watch & Wait Database: a retrospective, international, multicentre registry study [J].
Fernandez, Laura M. ;
Sao Juliao, Guilherme P. ;
Figueiredo, Nuno L. ;
Beets, Geerard L. ;
van der Valk, Maxime J. M. ;
Bahadoer, Renu R. ;
Hilling, Denise E. ;
Kranenbarg, Elma Meershoek-Klein ;
Roodvoets, Annet G. H. ;
Renehan, Andrew G. ;
van de Velde, Cornelis J. H. ;
Habr-Gama, Angelita ;
Perez, Rodrigo O. .
LANCET ONCOLOGY, 2021, 22 (01) :43-50
[7]   Outcome measures in multimodal rectal cancer trials [J].
Fokas, Emmanouil ;
Glynne-Jones, Robert ;
Appelt, Ane ;
Beets-Tan, Regina ;
Beets, Geerard ;
Haustermans, Karin ;
Marijnen, Corrie ;
Minsky, Bruce D. ;
Ludmir, Ethan ;
Quirke, Phil ;
Sebag-Montefiore, David ;
Garcia-Aguilar, Julio ;
Gambacorta, Maria Antonietta ;
Valentini, Vincenzo ;
Buyse, Marc ;
Rodel, Claus .
LANCET ONCOLOGY, 2020, 21 (05) :E252-E264
[8]   Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients [J].
Frin, Anne Claire ;
Evesque, Ludovic ;
Gal, Jocelyn ;
Benezery, Karene ;
Francois, Eric ;
Gugenheim, Jean ;
Benizri, Emmanuel ;
Chateau, Yan ;
Marcie, Serge ;
Doyen, Jerome ;
Gerard, Jean-Pierre .
EUROPEAN JOURNAL OF CANCER, 2017, 72 :124-136
[9]   Image Guided Adaptive Endorectal Brachytherapy in the Nonoperative Management of Patients With Rectal Cancer [J].
Garant, Aurelie ;
Magnan, Sindy ;
Devic, Slobodan ;
Martin, Andre-Guy ;
Boutros, Marylise ;
Vasilevsky, Carol-Ann ;
Ferland, Stephanie ;
Bujold, Alexis ;
DesGroseilliers, Sylvain ;
Sebajang, Herawaty ;
Richard, Carole ;
Te Vuong .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (05) :1005-1011
[10]  
Garcia-Aguilar J, 2020, J CLIN ONCOL, V38